INM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
InMed Pharmaceuticals Inc (INM) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows bearish technical indicators, declining financial performance, no positive news catalysts, and lacks significant trading trends or influential figure activity. Given the lack of positive signals and the investor's preference for long-term growth, this stock is not suitable at the moment.
The technical indicators are bearish. The MACD is negative and expanding downward, RSI is neutral but leaning towards oversold, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 0.682), with no signs of reversal.
NULL identified. No recent news or significant trading trends from hedge funds, insiders, or Congress.
is also down -1.79%, indicating negative market sentiment.
In 2026/Q2, the company reported declining financials. Revenue dropped to 820,188 (-26.22% YoY), net income dropped to -2,028,223 (-21.23% YoY), EPS dropped to -0.51 (-85.99% YoY), and gross margin dropped to 15.97 (-49.65% YoY).
No analyst rating or price target changes available.
